Other CIBMTR presentations will include additional results from ACCESS study; a trial in progress update on the ACCELERATE trial (NCT06859424), a platform protocol for testing multiple PTCy-based ...
Microsoft plans to remove Defender Application Guard from Office by December 2027, starting with the February 2026 release of ...
Tools like Excel and Google Sheets are ubiquitous these days, and learning how to use them more effectively will quickly ...
Datavault AI believes this technology has the potential to extend into a Pharmaceutical Exchange platform, which could transform the pharmaceutical industry by enabling efficient, secure asset ...
The global AI-Powered Pathology Market is projected to grow significantly in the coming years. It was valued at USD 184 Million in 2023 and is forecast to reach USD 382 Million by 2030, representing a ...
ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba ® is the subject of an exclusive, transferable license to use the ...
Nissan and INFINITI updated their pre- and post-repair scanning position statements on Nov. 1 to require the use of their ...
Hundreds of alcohol breath tests thought to have been inaccurate due to data entry errors are valid after all, officials from ...
| Dr. Bill Morice explains how advanced testing is reshaping treatment decisions and improving patient outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback